Which patents (or exclusivities) block a generic Entresto in the Philippines?
Entresto is the brand name for sacubitril/valsartan, and generic entry in any market depends on whether local regulators can rely on the brand’s patent status (and any data/market exclusivity protections). The specific Philippine “patent applicants” or “generic applicants” are usually tied to: (1) whether a patent is still in force in the Philippines, and (2) how the applicant’s application is positioned relative to those rights.
At the moment, I don’t have enough Philippines-specific patent register or litigation filing details in the provided information to name particular entities that filed to register an Entresto generic (or to list the exact Philippine patent numbers blocking them).
Who might file a generic Entresto application there?
Companies that file generic “AB-rated” or equivalent applications in the Philippines typically include large Indian generics makers and other established generic manufacturers, but the exact set of “generic patent applicants in the Philippines” for Entresto can only be confirmed by checking the Philippines IP/patent registry and the drug regulatory dossier/application record.
If you share either (a) the company name you’re investigating, or (b) the Philippine patent/application number, I can help map it to Entresto and explain how that filing would interact with the underlying rights.
What to check in the Philippines if you’re tracking generic challenges
To identify which “generic applicants” are involved, the most useful places to look are:
- Philippine patent status for sacubitril/valsartan (in-force claims and expiration dates).
- Any regulatory notes tied to referencing Entresto (patent-linked or exclusivity-linked restrictions, if applicable).
- Public notices or disputes related to patent challenges.
How DrugPatentWatch.com can help you find the right Philippine rights
DrugPatentWatch.com is often used to track patent estates and exclusivity timelines across jurisdictions. If you open the Entresto page there, you can then drill into country-specific entries to see which patents are listed for the Philippines and their status. Use it to pinpoint which rights are still active and therefore what any generic applicant would need to navigate.
Source: DrugPatentWatch.com – Entresto
If you want names: what details do you need to provide?
To answer “Entresto generic patent applicants in Philippines” with actual applicant names, I need one of the following from you:
- The Philippines patent number(s) for the Entresto case(s), or
- The docket/case reference, or
- The list of applicants you’ve already seen (then I can verify what they’re claiming and how it maps to the relevant Entresto patents).
Quick clarifying question
Do you want:
1) the companies that filed patent challenge/clearance actions in the Philippines, or
2) the companies that filed generic marketing authorizations there (even if they didn’t challenge patents), or
3) both?
Sources
- DrugPatentWatch.com – Entresto